This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: University of California, Frontier Medicines Corporation. Active years: 2020-2023.
Company Filing History:
2 out of 15,988 
1 out of 2 Years Active: 2020-2023
Title: The Innovations of Roberto Zoncu
Introduction
Roberto Zoncu is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the areas of targeted autophagy and mTORC1 modulation. With a total of 2 patents to his name, Zoncu's work has the potential to impact various therapeutic approaches.
Latest Patents
Zoncu's latest patents include innovative methods and compounds for targeted autophagy. These advancements provide new avenues for understanding and manipulating cellular processes. Additionally, he has developed methods and compounds for inhibiting mTORC1, which are crucial for treating diseases associated with mTORC1 activity.
Career Highlights
Throughout his career, Zoncu has worked with esteemed institutions such as the University of California and Frontier Medicines Corporation. His experience in these organizations has allowed him to refine his research and contribute to groundbreaking discoveries in his field.
Collaborations
Zoncu has collaborated with notable colleagues, including Daniel K Nomura and Hijai Shin. These partnerships have fostered a collaborative environment that enhances the potential for innovative breakthroughs.
Conclusion
Roberto Zoncu's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in medical science and therapeutic applications.